Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 13, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 17, 2026
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-054514
Filed / recorded
Feb 17, 2026, 8:58 PM UTC
Added to OQRO
Oct 6, 2026, 7:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CHEMED CORP
Issuer CIK
19584
Ticker
CHE
Reporting person
Joel L Wherley
Relationship
Officer
Officer title
CEO - Vitas Healthcare
Security
Performance Stock Units
Table
Derivative (Table II)
Transaction date
Feb 13, 2026
Transaction code
M
Shares / units
220
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
1,290
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.
PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.